Variant report
Variant | nsv470492 |
---|---|
Chromosome Location | chr2:142504502-142518602 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:142507099..142509499-chr2:142523507..142526473,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368868870 | chr2:142507270-142507271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569804393 | chr2:142507282-142507283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141285213 | chr2:142507288-142507289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370797999 | chr2:142507321-142507322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73963593 | chr2:142507324-142507325 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs192458705 | chr2:142507360-142507361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566315317 | chr2:142507370-142507371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535239010 | chr2:142507384-142507385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62168669 | chr2:142507417-142507418 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs62168670 | chr2:142507423-142507424 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs375641783 | chr2:142507426-142507427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535070863 | chr2:142507513-142507514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1437338 | chr2:142507524-142507525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577615168 | chr2:142507555-142507556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546496888 | chr2:142507571-142507572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560121770 | chr2:142507574-142507575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145008234 | chr2:142507589-142507590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184715138 | chr2:142507609-142507610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540132156 | chr2:142507666-142507667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562311331 | chr2:142507670-142507671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558527899 | chr2:142507675-142507676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188040474 | chr2:142507703-142507704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373478920 | chr2:142507730-142507731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs180896720 | chr2:142507731-142507732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186079864 | chr2:142507734-142507735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189746874 | chr2:142507763-142507764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535364649 | chr2:142507784-142507785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555233549 | chr2:142507789-142507790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569076549 | chr2:142507795-142507796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537542844 | chr2:142507799-142507800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:142507200-142507600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr2:142507200-142507800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |